Overview of Profenid Gel

Property	Description
Active ingredient	Ketoprofen
Form	Gel (Topical dosage form)
Pharmacological class	Non-steroidal Anti-Inflammatory Drug (NSAID)
Common use	Relief of localized pain and swelling
Origin	Synthetic (Propionic acid derivative)

Profenid Gel: Identity and Pharmacological Class

Profenid Gel is an external use medication defined by its single-component identity, containing the synthetic active compound, Ketoprofen. It is classified as a Non-steroidal Anti-Inflammatory Drug (NSAID), belonging specifically to the propionic acid derivative group, which is clinically recognized for its potent anti-inflammatory and analgesic properties. This pharmacological designation confirms its function as an anti-inflammatory agent and analgesic agent. Unlike oral NSAIDs, this topical medication is engineered for peripheral anti-inflammatory action, focusing the therapeutic effect directly at the site of application.

Composition, Form, and General Purpose

The composition features Ketoprofen suspended within a specialized hydrogel base, defining its topical dosage form. This Gel is designed for efficient cutaneous absorption, enabling the Ketoprofen to penetrate to the underlying soft tissues. Pharmacological studies have supported the premise that this topical delivery system minimizes systemic exposure while maximizing local concentration. The general purpose of Profenid Gel is to alleviate localized pain and reduce swelling often associated with common musculoskeletal disorders or soft tissue injury, offering focused symptomatic support without relying on extensive systemic distribution.

What side effects are possible with Profenid Gel?

Possible Side Effects and Safety Information

The most commonly documented adverse reactions associated with Profenid Gel (ketoprofen topical) are local skin reactions at the application site, including erythema, pruritus, and eczema, which are generally classified as Uncommon. Serious and clinically significant adverse reactions primarily involve photosensitivity reactions, which are classified as Rare but can be severe, including photoallergy and bullous dermatitis, sometimes requiring hospitalisation.

System-Organ Class	Frequency Classification	Adverse Reactions
Skin and Subcutaneous Tissue	Uncommon	Erythema, pruritus, eczema, rash, burning sensation
	Rare	Photosensitivity reactions, urticaria, bullous dermatitis
Gastrointestinal Disorders	Uncommon	Nausea (Systemic effects are rare due to low absorption)
Renal and Urinary Disorders	Very Rare	Worsening renal insufficiency (Isolated cases)

Safety Restrictions and Contraindications

Safety measures emphasize strict avoidance of sunlight or UV exposure to the treated area during use and for two weeks after stopping treatment due to the high risk of photosensitivity. Treatment must be immediately discontinued if any skin reaction occurs. The gel should not be applied to damaged skin (e.g., eczema, wounds) or mucous membranes.

Profenid Gel is contraindicated in patients with a known history of photosensitivity reactions to ketoprofen, tiaprofenic acid, fenofibrate, or a history of skin allergy to UV blockers/perfumes. Due to the class-wide risk of cardiovascular and renal toxicity in the fetus, use is strictly contraindicated during the third trimester of pregnancy and should be avoided in the first two trimesters and during lactation.

Overall Safety Profile

The regulatory safety profile for topical ketoprofen highlights that, while systemic absorption is low, the principal concern is managing the risk of local cutaneous reactions, particularly severe photoallergic reactions. Adherence to sun avoidance measures is mandatory to minimise this risk. Systemic adverse reactions, though very rare, include possible gastrointestinal effects and worsening of renal function, requiring caution in patients with pre-existing conditions.

Overdose and Emergency Response

The regulatory information for Profenid Gel (Topical Ketoprofen) states that overdose is unlikely following standard external application due to the minimal systemic absorption of the topical form. However, official guidance strictly addresses the management of accidental oral ingestion of the gel, linking potential effects to those seen with systemic NSAID overdose.

Overdose Manifestations and Actions

Feature	Official Regulatory Statement
Documented Overdose Presentations	Symptoms may include drowsiness, lethargy, nausea, vomiting, and epigastric (stomach) pain.
Physiological Systems Affected	Severe systemic overdose, though rare, may involve the Central Nervous System (e.g., seizures or coma), the Gastrointestinal system (bleeding), and Renal function (acute failure).
Emergency-Response Statement	Symptomatic and supportive treatment is the specified management approach. Activated charcoal may be considered for a large ingestion within four hours.
Antidote Status	No specific antidote is known for ketoprofen overdose.

When Immediate Medical Help is Required

Users are mandated to seek immediate medical attention or contact a poison control center (e.g., call 911 or the national Poison Help hotline) upon accidental oral ingestion of the gel. Urgent care is required for the manifestation of severe signs, including trouble breathing, convulsions, or loss of consciousness. Additionally, systemic exposure during the third trimester of pregnancy may carry a risk of cardiopulmonary and renal toxicity in the foetus.

Therapeutic Uses of Profenid Gel

What Profenid Gel Treats: Main Uses and Benefits

Profenid Gel is applied in clinical settings that involve symptoms related to inflammatory or irritative states that follow acute traumatic episodes affecting the soft tissues. Topical formulations of ketoprofen are generally used to help manage the localized pain and swelling from minor trauma, such as sprains, bruising, and acute muscle strains. This localized approach provides supportive relief when symptoms intensify and may assist with functional stability during symptomatic periods.

This medication is also relevant for easing the symptomatic discomfort associated with localized inflammatory disorders, including tendinitis, bursitis, tenosynovitis, and the pain and stiffness of localized osteoarthritis.

“This application assists with managing symptoms that interfere with daily comfort and supports patients during difficult episodes by easing distress.”

Applying the gel helps address symptom clusters that may become disruptive during flare-ups and helps ease the overall symptom burden during periods of heightened symptoms.

Quick Fact: Relief for Localized Pain and Inflammation

This medication is commonly used when short-term symptomatic assistance is needed for conditions presenting with localized pain and swelling due to inflammation, primarily in the musculoskeletal and periarticular domains.

Eligibility and Restrictions for Use

Eligibility for Profenid Gel: Official Regulatory Status

Official regulatory documentation defines eligibility for Profenid Gel based on patient history, age, pregnancy status, and environmental context. Use is generally established for adults and adolescents over 15 years of age.

Classification	Official Restriction
Absolute Contraindications	History of hypersensitivity to ketoprofen, aspirin, or other NSAIDs; history of photosensitivity reactions; application to broken or damaged skin (e.g., eczema, open wounds); and use during the third trimester of pregnancy.
Not Recommended	Children under 15 years of age (safety not established); women who are breastfeeding; use during the first and second trimesters of pregnancy.

Condition-Based and Environmental Rules

Patients with a history of asthma, allergic rhinitis, or severe renal impairment should use the gel with caution. A mandatory restriction exists regarding sun and UV light exposure: treated areas must not be exposed to sunlight, including hazy sun or solariums, during treatment and for a period of two weeks after discontinuation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The low systemic absorption of Profenid Gel (ketoprofen) means that interactions documented for the oral form are less likely but must still be considered, particularly in high-risk patients. Regulatory agencies classify the product's interaction profile into two main areas: mandatory local restrictions and precautionary systemic warnings.

Contraindicated External Interactions

To prevent severe local skin reactions, the following external factors and agents are strictly restricted during use and for two weeks after stopping treatment:

UV Light/Exposure: Avoidance of sun exposure (including solariums) on the treated area is mandatory.
Photosensitizing Agents: Do not combine with products containing octocrylene (a common UV filter) or perfumes on the application site.

Systemic Pharmacodynamic (PD) Precautionary Interactions

Although systemic exposure is low, caution and clinical monitoring are required when Profenid Gel is used concurrently with the following medications, due to the risk of additive systemic effects known from oral NSAIDs:

Product Category	Clinical Implication
Anticoagulants (e.g., Warfarin)	Increased risk of bleeding due to potential inhibition of platelet function.
Diuretics / ACE Inhibitors	Potential for reduced efficacy of these agents and increased risk of renal dysfunction.
Other NSAIDs (including high-dose Aspirin)	Increased risk of overall adverse effects, particularly gastrointestinal.
Methotrexate	Increased systemic exposure to methotrexate due to reduced clearance, particularly at high doses.

Mechanism of Action

How Profenid Gel Works

Profenid Gel works by engaging highly targeted mechanisms at the molecular level, primarily acting on the pathways responsible for generating molecular mediators of local tissue response. Its mechanism is peripheral, meaning the action is concentrated in the soft tissues at the application site.

Modulating Inflammatory Mediator Production

The core action of the drug is the non-selective, reversible inhibition of the Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. By blocking these enzymes, the drug suppresses the biosynthesis of key inflammatory mediators, such as Prostaglandin E2 ( PGE2), from the arachidonic acid cascade. This fundamental molecular intervention restricts the metabolic conversion within the arachidonic acid cascade.

Dampening Peripheral Nociceptor Signaling and Fluid Extravasation

The resulting decrease in PGE2 concentration leads to a bifunctional physiological consequence. First, it prevents the sensitization of peripheral nerve endings (nociceptors), which alters the necessary activation stimulus. Second, it limits vascular permeability and vasodilation, which reduces the extravasation of fluid into the tissue, resulting in a dampening of local volume increase (edema).

Dosage and Administration Information

How to Use Profenid Gel: Official Administration Guidelines

Profenid Gel (Ketoprofen 2.5% w/w) is a medication approved for cutaneous use (external application to the skin) only. The instructions for proper use are precisely defined to ensure accurate local delivery of the active substance while limiting systemic exposure.

Standard Dosing and Frequency

Administration must adhere to established limits:

Administration Rule	Official Instruction
Route of Use	Topical application to the skin
Dose per Application	Approximately 2 to 4 grams of gel (a strip 5 to 10 cm long)
Frequency	Two to four times daily on the affected area
Maximum Daily Limit	Should not exceed 15 grams per day

Application Technique and Duration

For administration, the measured amount of gel should be applied gently and then massaged thoroughly into the painful or inflamed area for a few minutes. Hands must be washed immediately and thoroughly after each application.

Treatment is intended for short-term use, generally limited to a maximum of 7 to 10 days. The principle of administration is to use the lowest effective dose for the shortest duration necessary.

Special Procedural Constraints

The gel must not be used in conjunction with occlusive dressings.
It is not recommended for use in children under 15 years of age.
The product must not come into contact with the eyes, mucous membranes, or be applied to broken or damaged skin.

Recent Clinical Evidence

Profenid Gel: Recent Clinical Evidence

Clinical research on topical ketoprofen (the active ingredient in Profenid Gel) has centered on its use for localized soft tissue injuries, pain management in joints, and musculoskeletal conditions.

Efficacy in Acute and Chronic Pain

Randomized controlled trials (RCTs) have consistently evaluated topical ketoprofen's role in conditions such as osteoarthritis of the knee and hand and acute musculoskeletal injuries (e.g., sprains and strains). Findings from several meta-analyses suggest that topical ketoprofen, when compared to a non-medicated placebo, is associated with a greater proportion of participants achieving a substantial reduction in pain.

One large review, focusing on chronic conditions like osteoarthritis, reported that topical ketoprofen demonstrated a statistically significant difference in pain relief compared to placebo over a period of 6 to 12 weeks.
For acute painful conditions, studies have shown that topical application may provide effective pain relief within one week, with effects attributed to the high local concentration achieved in the tissue beneath the application site.

Tolerability and Systemic Absorption

Topical administration is associated with a lower systemic absorption profile compared to oral non-steroidal anti-inflammatory drugs (NSAIDs). This difference is relevant for tolerability, as the risk of systemic adverse events, particularly those affecting the gastrointestinal system, is significantly reduced with the topical gel.

Area of Comparison	Topical Ketoprofen Gel (vs. Placebo)
Local Skin Reactions	Commonly reported (e.g., erythema, pruritus); typically mild
Systemic GI Adverse Events	Comparable incidence to placebo (low)
Photosensitivity Risk	Requires strict avoidance of sun exposure during treatment and for two weeks after discontinuation

Guidelines and Clinical Positioning

Clinical guidelines from international rheumatology organizations often suggest that topical NSAIDs, including ketoprofen gel, may be considered a preferred initial treatment option for patients experiencing mild to moderate osteoarthritis in only a few joints, particularly for those who have an increased risk of systemic side effects from oral NSAIDs.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Profenid Gel (FAQ)

Q: How quickly should I expect Profenid Gel to start working after I use it?

Studies examining how the body handles the medicine indicate that the active substance reaches its maximum level of absorption in the blood approximately 0.6 to 1 hour after it is applied to the skin. This measure, known as Tmax, gives an indirect indication of the time it takes for the substance to be available for its action.

Q: How long does the pain relief from Profenid Gel typically last?

Regulatory documents describe the typical frequency of application as two to four times daily. This prescribed frequency suggests the period for which the therapeutic effect is intended to last before reapplication is needed.

Q: Can Profenid Gel be used long-term for chronic joint issues?

Official administration guidelines state that treatment should be limited to the shortest possible period. The maximum recommended duration of use is generally not intended to exceed 7 to 10 days in total.

Q: Why do official documents mention restrictions on who can use Profenid Gel?

Regulatory restrictions are in place to ensure patient safety based on scientific evidence. For example, the contraindication during late pregnancy is due to documented risks of serious effects on the developing fetus. For individuals under 15 years old, use is not recommended because the safety and effectiveness for this age group have not been fully established.

Q: Does alcohol consumption affect how Profenid Gel works or its safety?

Official information indicates that systemic drug interactions are unlikely because the concentration of the active substance that reaches the bloodstream after topical application is low. Therefore, the risk of interactions often associated with oral pain relievers, such as those related to alcohol, is considered low.

Q: What should I do if a child accidentally touches the area where Profenid Gel was applied?

The official documentation includes the instruction that hands should be washed thoroughly immediately after applying the gel. This measure is important to prevent the accidental transfer of the medicine to sensitive areas, such as a child's eyes or mouth.

Q: Can Profenid Gel be used with wraps or bandages?

The official product information states that the gel is not to be used in conjunction with occlusive dressings. An occlusive dressing is a covering that is non-porous and creates an airtight or watertight seal over the application site.

Q: Does the strength (percentage) of Profenid Gel make a big difference in relief?

Clinical studies have examined different strengths of topical ketoprofen. These studies have shown differences in the amount of the active substance absorbed into the body (systemic exposure) depending on the concentration used.

Q: If I have kidney problems, is Profenid Gel still safe to use?

Regulatory documents advise that the gel should be used with caution in individuals who have reduced kidney function or a history of severe renal impairment. This warning is based on very rare reports of worsening kidney insufficiency associated with the drug.

Q: Why is it important to wash my hands after using Profenid Gel?

Washing hands immediately after application is an instruction documented in the product information to help prevent the accidental transfer of the gel to sensitive areas, such as the eyes and mucous membranes. It also helps to reduce the risk of photosensitivity reactions spreading to your hands.

Q: Can Profenid Gel be used for nerve pain?

The product's therapeutic use is specifically indicated for the relief of localized pain and swelling associated with musculoskeletal disorders and soft tissue injury, such as sprains, strains, and tendonitis.

Q: Are there known interactions between Profenid Gel and herbal supplements?

Official documentation does not typically list specific interactions with herbal supplements. However, it states that systemic interactions are unlikely because the concentration of the medicine in the bloodstream is low after topical application.

Q: What is the role of the inactive ingredients in Profenid Gel?

The active ingredient, ketoprofen, is suspended within a specialized hydrogel base. This base, which contains the inactive ingredients, is designed to facilitate the delivery and absorption of the active substance into the underlying soft tissues.

Q: Does Profenid Gel contain parabens or other preservatives?

The full list of inactive ingredients, or excipients, used in the formulation of the gel is required to be formally disclosed in regulatory documentation, typically found in the Composition section of the product information.

Q: Are there any specific concerns about using Profenid Gel in warm climates?

The primary concern in warm or sunny climates is the restriction in official labeling against exposing treated skin to UV light or sunlight. This includes hazy sun or solariums and must be avoided during treatment and for two weeks after it is stopped, due to the risk of photosensitivity.

Q: Can Profenid Gel interact with topical anti-inflammatory creams that are not NSAIDs?

Official documentation warns against combining the gel with other NSAIDs (oral or topical) or certain UV filters and perfumes. Outside of these specified items, systemic interactions are considered unlikely due to the low concentration of the medicine in the bloodstream.

Q: What is the recommended duration of treatment with Profenid Gel before seeing a doctor?

The maximum duration of use is generally limited to 7 to 10 days. Official patient information indicates that a healthcare professional should be consulted if symptoms continue or worsen during this period.

Q: Does Profenid Gel have a risk of addiction?

The active ingredient in Profenid Gel, ketoprofen, is a Non-steroidal Anti-Inflammatory Drug (NSAID). Official classification by government health authorities indicates that this drug class is not associated with a risk of dependence.

Q: Is Profenid Gel effective for chronic lower back pain?

Clinical reviews of topical ketoprofen have examined its use in the treatment of various chronic pain conditions, including research on its effectiveness in relieving back pain.

Q: What happens if I accidentally put Profenid Gel on broken skin?

Official product information states that application of the gel to broken, damaged, or infected skin (e.g., open wounds or eczema) is prohibited. Applying it to damaged skin may increase the risk of local adverse reactions, which is a key caution in the safety profile.

Q: Does Profenid Gel show up on drug tests?

Studies on the active ingredient, ketoprofen (typically administered orally), have indicated a potential to cause a false positive result for certain substances in preliminary drug screening tests, due to chemical cross-reactivity.

Q: Can I use Profenid Gel if I am already taking an oral NSAID like ibuprofen?

Regulatory warnings advise caution if the gel is used at the same time as other Non-steroidal Anti-Inflammatory Drugs (NSAIDs), including those taken by mouth. This combination can increase the risk of overall systemic adverse effects.

Q: Can older adults use Profenid Gel without special precautions?

Regulatory documents describe the intended use for adults over 15 years of age. However, caution is advised for patients with pre-existing conditions, such as reduced kidney function, which can be more common in older adults, as specified in regulatory warnings.

How should Profenid Gel be stored and disposed of?

Storage Requirements for Profenid Gel

Official labeling mandates that Profenid Gel must be stored at Controlled Room Temperature, typically below 25 C (77 F) or 30 C (86 F), depending on the regulatory region. The product must be kept from freezing and protected from excessive moisture and light. To maintain product stability, the gel must remain in its original container with the cap tightly closed when not in use. A non-negotiable regulatory requirement is to store the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Profenid Gel should be disposed of by utilizing an authorized drug take-back program or mail-back service. If those options are not available, the product may be discarded in the household trash by first mixing the gel with an unappealing substance, such as dirt or used coffee grounds, and placing the mixture in a sealed container.

Profenid Gel